Michael Putman, MD, MSCI
Assistant Professor
Locations
- Froedtert Hospital
- Rheumatology - Froedtert Hospital
Specialties
- Rheumatology
Languages
- English, Spanish
New & Established Patients Call
Education
- MD - Doctor of Medicine
- MSCI -Master of Science in Clinical Investigation
Biography
After graduating from Vanderbilt University in Nashville, TN, I returned to the Midwest for medical school at the University of Chicago, where I also completed a residency in internal medicine. From there I have migrated steadily northwards, first completing a year as Chief Resident at Mercy Hospital, a University of Chicago affiliate, and then pursuing a rheumatology fellowship at Northwestern University. I stayed on for an extra year to complete a T32 training grant, during which I developed a clinical and research focus in vasculitis.
Currently, I am doing the (much discouraged!) even split of patient care, research, and teaching. From a patient care perspective, I am the Medical Director of the Vasculitis Program, run the Fast Track GCA Clinic, and serve on the Innovative Therapies P&T committee. I also staff a general rheumatology clinic and have always been a generalist at heart! On the educational side, I am an Associate Program Director for both the rheumatology fellowship and the internal medicine residency. I am also the block director for the medical school hematology/immunology course and love teaching all levels of medical trainees. My research interests include clinical trials in vasculitis, “big data” epidemiology, and meta-research (i.e. researching research!). I am currently an Associate Editor of the journal Rheumatology and host the Evidence Based Rheumatology podcast.
In my off hours I like to spend time outdoors with my wife and three kids. I am also a hobby-enthusiast (always looking for another skill to learn!) and enjoy cooking, building things, and growing flowers/veggies in our gardens.
Publications
-
Barriers to CAR T-cell therapy in rheumatology.
(Lungova K, Putman M.) Lancet Rheumatol. 2024 Nov 05 PMID: 39515366 11/13/2024
-
(Jiang Y, Duarte-García A, Putman M, Gazeley D.) J Rheumatol. 2024 Nov 01 PMID: 39486853 11/02/2024
-
The emerging risk of overdiagnosis in rheumatoid arthritis and polymyalgia rheumatica.
(Nettleton E, Carlson K, Putman M.) Lancet Rheumatol. 2024 Sep 25 PMID: 39341221 09/29/2024
-
The State of Patient-Reported Outcome Measures in Rheumatology.
(Manswell K, Le V, Henry K, Casey M, Anumolu N, Putman MS.) J Rheumatol. 2024 Sep 01;51(9):920-927 PMID: 38825357 SCOPUS ID: 2-s2.0-85203029520 06/03/2024
-
(Figueroa-Parra G, Cuéllar-Gutiérrez MC, González-Treviño M, Sanchez-Rodriguez A, Flores-Gouyonnet J, Meade-Aguilar JA, Prokop LJ, Murad MH, Dall'Era M, Rovin BH, Houssiau F, Tamirou F, Fervenza FC, Crowson CS, Putman MS, Duarte-García A.) Arthritis Rheumatol. 2024 Sep;76(9):1408-1418 PMID: 38766897 SCOPUS ID: 2-s2.0-85197467558 05/20/2024
-
Positive and negative controls in rheumatology research.
(Kelly A, Carlson K, Wallace Z, Putman M.) Rheumatology (Oxford). 2024 Aug 02 PMID: 39093004 08/02/2024
-
(Casey M, Pannu S, Bajwa S, Duarte-García A, Putman M.) Arthritis Care Res (Hoboken). 2024 Aug;76(8):1203-1209 PMID: 38570894 SCOPUS ID: 2-s2.0-85192147298 04/04/2024
-
(Gill B, Putman M.) Lancet Rheumatol. 2023 Dec;5(12):e698-e699 PMID: 38251556 01/22/2024
-
Should race be considered in diagnosing giant cell arteritis? - Authors' reply.
(Gill T, Putman M, Sattui SE, Hamdulay S, Conway R, Liew DFL, Sharma A, Stone JH, Mackie SL, Mehta P.) Lancet Rheumatol. 2023 Jul;5(7):e372-e373 PMID: 38251547 01/22/2024
-
(Singla S, Putman M, Liew J, Gordon K.) Lancet Rheumatol. 2023 Jun;5(6):e313 PMID: 38251598 01/22/2024
-
(Singla S, Putman M, Liew J, Gordon K.) Lancet Rheumatol. 2023 Apr;5(4):e200-e207 PMID: 38251522 01/22/2024
-
Giant cell arteritis can occur in people of colour.
(Gill T, Putman M, Sattui SE, Hamdulay S, Conway R, Liew DFL, Sharma A, Stone JH, Mackie SL, Mehta P.) Lancet Rheumatol. 2023 Apr;5(4):e175-e177 PMID: 38251515 01/22/2024